Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-22-017337
Filing Date
2022-05-02
Accepted
2022-05-02 17:20:34
Documents
3
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20002080x1_pre14a.htm PRE 14A 255484
2 ny20002080x1_pc01.jpg GRAPHIC 827945
3 ny20002080x1_pc02.jpg GRAPHIC 773526
  Complete submission text file 0001140361-22-017337.txt   2461712
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-15771 | Film No.: 22883310
SIC: 2834 Pharmaceutical Preparations